The hustle of modern life can leave nutrient levels depleted, affecting everything from energy to immune function
Numerous studies have shown an increase of systemic oxidative stress markers in the lungs of cigarettes smokers and COPD patients without and with inherited AATD
Medical supervision importance Medical supervision provides crucial risk mitigation
This rigorous purification strips away almost all the fat and lactose, resulting in a highly refined powder that is 90% or more pure protein by weight
Free specialist consultation Benefits Separate from GLP-1 mechanism synergy when combined with Ozempic/Mounjaro 22.7% weight loss in CagriSema (REDEFINE-1, 68 weeks) best result among incretin therapies 10.8% in monotherapy over 26 weeks (Phase 2, Lancet 2021) In T2D on metformin: 15.6% weight, 2.2% HbA1c combined with semaglutide Does NOT cause hypoglycemia (unlike insulin and sulfonylureas) Gradual 16-week titration smooth buildup, minimal side effects Convenient weekly dosing half-life ~7 days Cardiovascular risk reduction in T2D (secondary endpoint REDEFINE-2) Alternative/addition for patients plateauing on GLP-1 monotherapy Who it's for Weight plateau on GLP-1 (Ozempic/Mounjaro) adding cagrilintide gives +610% reduction Patients who don't tolerate high GLP-1 doses lower dose + cagrilintide instead of dose increase T2D on metformin better glycemic and weight control than semaglutide-mono Biohackers / advanced users seeking maximum CagriSema protocol effect Post-surgical weight maintenance (bariatric) adjuvant against recidivism Those wanting SEPARATE appetite control mechanism without duplicating GLP-1 How to take Standard 16-week titration (Novo Nordisk Phase 3 CagriSema): Weeks 14: 0.25 mg subcutaneous once weekly
Food Funct 12(24):1223512249 Narayanan VS, Muddaiah S, Shashidara R, Sudheendra U, Deepthi N, Samaranayake L (2020) Variable antifungal activity of curcumin against planktonic and biofilm phase of different candida species
